Age: 4.0
Sex: M
Vaccine: IPV, MNQ, TDAP
Symptoms: Product storage error
Clinical narrative: temperature excursion involving punctured IPOL and unopened ADACEL and MENACTRA range from 31.7F to 52.4F for 300 hours due to a refrigerator malfunction (not human error) with no reported adverse event; The IPOL has been administered once, ADACEL administered three times and MENACTRA administered twice since the excursion with no reported adverse event; Initial information received on 22-Jul-2022 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a 4 years old male patient who had temperature excursion involving punctured ipol and unopened adacel and menactra range from 31.7f to 52.4f for 300 hours due to a refrigerator malfunction (not human error) with no reported adverse event and the ipol has been administered once, adacel administered three times and menactra administered twice since the excursion with no reported adverse event while receiving vaccines MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA], DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL] and IPV (VERO) [IPOL].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 05-APR-2022 there was a temperature excursion involving punctured ipol and unopened adacel and menactra range from 31.7f to 52.4f for 300 hours due to a refrigerator malfunction (not human error) with no reported adverse event (product storage error).  On 19-Jul-2022, the patient received a dose of 0.5 ml of suspect IPV (VERO) (formulation, strength: unknown) lot V1A024M, expiration date: 17-Feb-2024, via intramuscular route in the right thigh as immunization.  On 19-JUL-2022 the ipol has been administered once, adacel administered three times and menactra administered twice since the excursion with no reported adverse event (poor quality product administered) same day following the administration of IPV (VERO) and  (unknown latency) following the administration of other suspects. This situation was reported as a medication error due to administration post excursion.  On an unknown date, the patient received an unknown dose of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE (formulation, strength: unknown) lot number not reported in unknown administration site as Immunization.  On an unknown date, the patient received an unknown dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE(formulation, strength: unknown) lot number not reported in unknown administration site as Immunization. Lot numbers were requested.  Action taken was not applicable.  At time of reporting, the outcome was Unknown for both events.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.